XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Acquisitions (Details) - USD ($)
Nov. 07, 2023
Dec. 31, 2021
Dec. 31, 2022
Vesta Intermediate Funding, Inc | Scenario Forecast | First Milestone Price Target      
Business Acquisition [Line Items]      
Number of days within which additional shares will be issued 5 days    
Vesta Intermediate Funding, Inc | Scenario Forecast | Second Milestone Price Target      
Business Acquisition [Line Items]      
Number of days within which additional shares will be issued 5 days    
AuraGen Aesthetics LLC      
Business Acquisition [Line Items]      
Asset purchase agreement date   Dec. 31, 2021  
Payment to acquire business   $ 1,000,000  
Fair value of deferred cash consideration   2,400,000  
Fair value of contingent consideration   $ 2,600,000  
Fair value measurement discount rate   20.00%  
Stock issued during period, shares   3,930,655  
AuraGen Aesthetics LLC | Maximum      
Business Acquisition [Line Items]      
Contingent consideration liability   $ 8,500,000  
AuraGen Aesthetics LLC | Scenario Forecast      
Business Acquisition [Line Items]      
Contingent consideration liability     $ 3,000,000